Mike Meyer
Investor Relations Representative
Replay available
Cognition Therapeutics, Inc. (NASDAQ: CGTX) Q4 2023 earnings conference call, held 2024-03-26. Replay captured from the company's public earnings webcast.

Investor Relations Representative
President and Chief Executive Officer
Chief Financial Officer
Chief Medical Officer
Analyst, Cantor Fitzgerald
Analyst, Oppenheimer
Analyst, B. Riley Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Cognition Therapeutics, Inc..
WEBVTT 00:00:00.009 -- 00:00:05.312 Hello, everyone, and welcome to Cognition Therapeutics' fourth quarter 2023 earnings 00:00:05.312 -- 00:00:09.094 call. Please note that this call is being recorded. 00:00:09.094 -- 00:00:13.176 I'd now like to hand over to our first speaker for today, Mike Meyer. 00:00:13.176 -- 00:00:15.717 Please go ahead. 00:00:16.558 -- 00:00:18.480 Thank you, operator, and good morning, everyone. 00:00:18.480 -- 00:00:23.202 Welcome to the Cognition Therapeutics' fourth quarter and year-end 2023 results conference 00:00:23.202 -- 00:00:28.205 call. With me today are Lisa Ricciardi, President and Chief Executive Officer, 00:00:28.205 -- 00:00:30.807 John Doyle, Chief Financial Officer, and Dr. 00:00:30.807 -- 00:00:36.188 Tony Caggiano, Chief Medical Officer. This morning, the company issued a press release 00:00:36.188 -- 00:00:39.769 detailing its 2023 fourth quarter and year-end results. 00:00:39.769 -- 00:00:43.390 We encourage everyone to read this morning's press release, as well as Cognition's annual 00:00:43.390 -- 00:00:48.692 report on Form 10-K, which is now filed with the SEC and available on our website. 00:00:48.692 -- 00:00:52.332 In addition, this conference call is being webcast to the company's website and will 00:00:52.332 -- 00:00:57.034 be archived for 30 days. Please note that certain information discussed on the call today 00:00:57.034 -- 00:01:01.170 is covered under the Safe Harbor provisions of the Private Securities Litigation Reform 00:01:01.170 -- 00:01:04.672 Act. We caution listeners that during the call, management will be making forward-looking 00:01:04.672 -- 00:01:09.094 statements. Actual results could differ materially from those stated or implied by these 00:01:09.094 -- 00:01:12.196 forward-looking statem...